Polyaromatic hydrocarbons are ubiquitous environmental pollutants that are potent mutagens and carcinogens. Researchers have taken advantage of these properties to investigate the mechanisms by which chemicals cause cancer of the skin and other organs. When applied to the skin of mice, several carcinogenic polyaromatic hydrocarbons have also been shown to interact with the immune system, stimulating immune responses and resulting in the development of antigen specific T-cell mediated immunity. Development of cell-mediated immunity is strain specific and is governed by Ah receptor genes and by genes located within the major histocompatibility complex. CD8 + T-cells are effector cells in the response, whereas CD4 + T-cells down-regulate immunity. Development of an immune response appears to have a protective effect since strains of mice that develop a cell-mediated immune response to carcinogenic polyaromatic hydrocarbons are less likely to develop tumors when subjected to a polyaromatic hydrocarbon skin carcinogenesis protocol than mice that fail to develop an immune response. With respect to innate immunity, TLR4 deficient C3H/HeJ mice are more susceptible to polyaromatic hydrogen skin tumorigenesis than C3H/HeN mice in which TLR4 is normal. These findings support the hypothesis that immune responses, through their interactions with chemical carcinogens, play an active role in the prevention of chemical skin carcinogenesis during the earliest stages. Efforts to augment immune responses to the chemicals that cause tumors may be a productive approach to the prevention of tumors caused by these agents. Keywords polyaromatic hydrocarbon; contact hypersensitivity; skin carcinogenesis; dimethylbenz(a) anthracene; benzo(a)pyrene; immunotoxicology The polyaromatic hydrocarbons benzo(a)pyrene [B(a)P] 1 and dimethylbenz(a)anthracene (DMBA) are potent mutagens and carcinogens when applied to the skin. These chemicals are often employed to investigate the mechanisms by which xenobiotics cause cancer. A single application of DMBA or B(a)P results in the formation of stable adducts with the DNA of target cells, leading to mutations in the H-ras oncogene. Repeated exposure of the carcinogen treated skin to tumor promoters such as 12-O-tetradecanoyl-phorbol-13-acetate (TPA), benzoyl peroxide or mezerin produces epigenetic changes in the H-ras mutant cells that convert Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Skin tumors induced by carcinogenic polyaromatic hydrocarbons (PAHs) express tumor specific antigens that elicit a cell-mediated immune response. Immunotherapeutic app...